Altimmune Inc
For the period ended Dec 31, 2023. Filed Mar 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 27, 2024
ALT$1.94-8.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
4. Property and Equipment, Net
- Property and Equipment, Net
Property and equipment, net consists of the following (in thousands):
| | | | | | | |
|---|---|---|---|---|---|---|
| · · December 31, | ||||||
| · · 2023 · · 2022 | ||||||
| Furniture, fixtures and equipment | $163 | | 163 | |||
| Laboratory equipment | | 342 | | 295 | ||
| Computers and telecommunications | | 194 | | 194 | ||
| Software | | 178 | | 178 | ||
| Leasehold improvements | | 1,749 | | 1,749 | ||
| Property and equipment, at cost | | 2,626 | | 2,579 | ||
| Less: accumulated depreciation and amortization | | | (1,975) | | | (1,498) |
| Property and equipment, net | | $651 | | $1,081 | ||
Depreciation expense related to property and equipment for each of the years ended December 31, 2023 and 2022 was $0.5 million.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.